PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 98 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $39,000 | -27.8% | 11,434 | -0.7% | 0.00% | – |
| Q2 2019 | $54,000 | +38.5% | 11,510 | -1.5% | 0.00% | – |
| Q1 2019 | $39,000 | +34.5% | 11,689 | +7.9% | 0.00% | – |
| Q4 2018 | $29,000 | -97.2% | 10,833 | -94.1% | 0.00% | -100.0% |
| Q3 2018 | $1,036,000 | +20.0% | 184,931 | +8.6% | 0.00% | 0.0% |
| Q2 2018 | $863,000 | -32.5% | 170,254 | -9.2% | 0.00% | 0.0% |
| Q1 2018 | $1,278,000 | – | 187,402 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 778,230 | $5,308,000 | 5.22% |
| BVF INC/IL | 3,592,549 | $24,501,000 | 2.48% |
| Prosight Management, LP | 563,763 | $3,845,000 | 2.41% |
| SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $5,456,000 | 0.83% |
| Virtus ETF Advisers LLC | 125,695 | $857,000 | 0.74% |
| EAM Investors, LLC | 521,460 | $3,556,000 | 0.59% |
| Tekla Capital Management LLC | 2,087,380 | $14,236,000 | 0.55% |
| Orbimed Advisors | 5,550,000 | $37,851,000 | 0.47% |
| EAM Global Investors LLC | 125,635 | $857,000 | 0.44% |
| Schonfeld Strategic Advisors LLC | 830,637 | $5,665,000 | 0.42% |